1 reports of this reaction
3.8% of all CAMPHOR (SYNTHETIC) reports
#10 most reported adverse reaction
INTENSIVE CARE is the #10 most commonly reported adverse reaction for CAMPHOR (SYNTHETIC), manufactured by Kaz USA, Inc. There are 1 FDA adverse event reports linking CAMPHOR (SYNTHETIC) to INTENSIVE CARE. This represents approximately 3.8% of all 26 adverse event reports for this drug.
Patients taking CAMPHOR (SYNTHETIC) who experience intensive care should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENSIVE CARE is moderately reported among CAMPHOR (SYNTHETIC) users, representing a notable but not dominant share of adverse events.
In addition to intensive care, the following adverse reactions have been reported for CAMPHOR (SYNTHETIC):
INTENSIVE CARE has been reported as an adverse event in 1 FDA reports for CAMPHOR (SYNTHETIC). This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENSIVE CARE accounts for approximately 3.8% of all adverse event reports for CAMPHOR (SYNTHETIC), making it a notable side effect.
If you experience intensive care while taking CAMPHOR (SYNTHETIC), contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.